Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03265431 · ClinicalTrials.gov registry record · Phase 2

Evaluation of PET/MR in Patients Selected for Ablation Therapy

A Phase 2 study of Arrhythmias, Cardiac, sponsored by Massachusetts General Hospital.

Active
Registry status
Phase 2
Development phase
34
Enrollment target
1
Study location

NCT03265431 is a Phase 2 study of Arrhythmias, Cardiac that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 34 participants, below the 560-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03265431, a Phase 2 study of Arrhythmias, Cardiac, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This study is performed to assess if PET-MR imaging can improve treatment of patients with irregular heart rate and heart failure. Heart failure occurs when the heart muscle is too weak to do his work correctly. Irregular heart rate can be related to numerous diseases. One category of irregular heart rate is called ventricular arrhythmia. It is often seen in patients who have had a heart attack. This type of arrhythmia can be dangerous and can cause sudden death. To prevent these arrhythmias, doctors can perform procedures that burn the source of arrhythmia in the heart muscle. This is called ablation. Unfortunately, ablation does not fix the problem in 100% of patients and some will still have the arrhythmia requiring repeated procedure. The purpose of this study is to find new ways of guiding the doctors performing ablation, hoping to improve the success rate of the procedure.

Conditions Studied

Arrhythmias, Cardiac

Interventions

  • DRUG 18F-TPP

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-07-14
Est. Completion 2027-06-30
Phase Phase 2

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03265431

The ClinicalTrials.gov registry entry for NCT03265431 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 560-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target (94% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arrhythmias, Cardiac appearing as the primary indexed condition, and to 1 intervention - of which 18F-TPP is the first listed.

NCT03265431 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03265431 about?

NCT03265431 is a clinical study titled "Evaluation of PET/MR in Patients Selected for Ablation Therapy". This study is performed to assess if PET-MR imaging can improve treatment of patients with irregular heart rate and heart failure. Heart failure occurs when the heart muscle is too weak to do his work correctly. Irregular heart rate can be related to numerous diseases. One category of irregular hear...

What is the current status of trial NCT03265431?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2017-07-14. Estimated completion is 2027-06-30.

What conditions does trial NCT03265431 study?

This clinical trial studies the following conditions: Arrhythmias, Cardiac.

What interventions are being tested in trial NCT03265431?

The interventions under investigation include: 18F-TPP (DRUG).

Who is sponsoring clinical trial NCT03265431?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03265431 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arrhythmias, Cardiac

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arrhythmias, Cardiac

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.